A Day Up For Provention Bio, Inc.
Tue, May 25, 2021 at 05:30 PM
Provention Bio, Inc. (PRVB:NASDAQ) jumped higher at $10.12, representing a gain of 26.8%. On Mon, May 24, 2021, PRVB:NASDAQ touched a New 2-Week High of $7.98. The stock got featured on our News Catalysts scanner on Tue, May 25, 2021 at 02:56 PM in the 'INVESTOR UPDATE' category. From Mon, May 10, 2021, the stock recorded 50.00% Up Days and 54.55% Green Days
The share price of the company has been moving sideways in recent weeks.
About Provention Bio, Inc. (PRVB:NASDAQ)
Provention Bio Inc is a clinical-stage biopharmaceutical company. It is engaged in the sourcing, developing and commercializing novel therapeutics and cutting-edge solutions to intercept and prevent immune-mediated disease. The company's pipeline includes PRV-031, PRV-6527, PRV-300, PRV-3279, and PRV-101.
Top 10 Gainers:
- Pieris Pharmaceuticals, Inc. (PIRS:NASDAQ), 103.24%
- SPBC (SPBC:NASDAQ), 100%
- MSDA (MSDA:NASDAQ), 100%
- Flanigan's Enterprises, Inc. (BDL:NYSEMKT), 40.58%
- Moxian, Inc. (MOXC:NASDAQ), 30.33%
- Taiwan Liposome Company, Ltd. (TLC:NASDAQ), 28.69%
- Provention Bio, Inc. (PRVB:NASDAQ), 26.82%
- Reading International, Inc. (RDIB:NASDAQ), 26.81%
- Lianluo Smart Limited (LLIT:NASDAQ), 24.59%
- Friedman Industries, Incorporated (FRD:NYSEMKT), 24.36%